Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report) shares traded up 6.1% during trading on Friday . The stock traded as high as $0.5142 and last traded at $0.5140. 1,012,728 shares changed hands during mid-day trading, a decline of 13% from the average session volume of 1,158,794 shares. The stock had previously closed at $0.4845.
Elite Pharmaceuticals Trading Up 1.7%
The company’s 50-day moving average is $0.56 and its 200 day moving average is $0.60. The company has a current ratio of 8.04, a quick ratio of 6.34 and a debt-to-equity ratio of 0.06. The firm has a market cap of $529.51 million, a PE ratio of 49.33 and a beta of 0.29.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
Read More
- Five stocks we like better than Elite Pharmaceuticals
- BNZI Posts Record Q3 Revenue – See What’s Driving It.
- End of America update
- Do you know what Amazon is planning for January 1?
- Turn your “dead money” into $306+ monthly (starting this month)
- Protect Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
